Next Article in Journal
The Future Public Health Workforce in a Changing World: A Conceptual Framework for a European–Israeli Knowledge Transfer Project
Next Article in Special Issue
Is Technological Progress Selective for Multiple Pollutant Emissions?
Previous Article in Journal
Physical Exercise and Psychological Distress: The Mediating Roles of Problematic Mobile Phone Use and Learning Burnout among Adolescents
Previous Article in Special Issue
Municipality Data as a Rapid and Effective Tool to Analyse Spatial and Temporal Variations of All-Cause Mortality by Town District: The Experience in Genoa (Italy)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 18
Issue 17
10.3390/ijerph18179262
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Variation of Cancer Incidence between and within GRELL Countries

by
Paolo Contiero
1,
Giovanna Tagliabue
2,*,
Gemma Gatta
3,
Jaume Galceran
4,
Jean-Luc Bulliard
5,6,
Martina Bertoldi
1,
Alessandra Scaburri
1,
Emanuele Crocetti
7 and
on behalf of the GRELL Geographic Analysis Working Group
†
1
Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
2
Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
3
Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
4
Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Sant Joan de Reus University Hospital, IISPV, 43204 Reus, Spain
5
Vaud Tumour Registry, Centre for Primary Care and Public Health, University of Lausanne, 1010 Lausanne, Switzerland
6
Neuchâtel-Jura Tumour Registry, 2000 Neuchâtel, Switzerland
7
Romagna Cancer Registry, Romagna Cancer Institute (IRCCS Istituto Romagnolo Per Lo Studio dei Tumori (IRST) “Dino Amadori”), 47014 Meldola, Italy
*
Author to whom correspondence should be addressed.
†
Participants are listed in Acknowledgments.
Int. J. Environ. Res. Public Health 2021, 18(17), 9262; https://doi.org/10.3390/ijerph18179262
Submission received: 14 July 2021 / Revised: 26 August 2021 / Accepted: 27 August 2021 / Published: 2 September 2021
(This article belongs to the Special Issue From Environmental Health Inequalities to Environmental Health Justice)
Browse Figure
Review Reports Versions Notes

Abstract

:
Variation in cancer incidence between countries and groups of countries has been well studied. However cancer incidence is linked to risk factors that may vary within countries, and may subsist in localized geographic areas. In this study we investigated between- and within-country variation in the incidence of all cancers combined for countries belonging to the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). We hypothesized that investigation at the micro-level (circumscribed regions and local cancer registry areas) would reveal incidence variations not evident at the macro level and allow identification of cancer incidence hotspots for research, public health, and to fight social inequalities. Data for all cancers diagnosed in 2008–2012 were extracted from Cancer Incidence in Five Continents, Vol XI. Incidence variation within a country or region was quantified as r/R, defined as the difference between the highest and lowest incidence rates for cancer registries within a country/region (r), divided by the incidence rate for the entire country/region × 100. We found that the area with the highest male incidence had an ASRw 4.3 times higher than the area with the lowest incidence. The area with the highest female incidence had an ASRw 3.3 times higher than the area with the lowest incidence. Areas with the highest male ASRws were Azores (Portugal), Florianopolis (Brazil), Metropolitan France, north Spain, Belgium, and north-west and north-east Italy. Areas with the highest female ASRws were Florianopolis (Brazil), Belgium, north-west Italy, north-east Italy, central Italy, Switzerland and Metropolitan France. Our analysis has shown that cancer incidence varies markedly across GRELL countries but also within several countries: the presence of several areas with high cancer incidence suggests the presence of area-specific risk factors that deserve further investigation.

1. Introduction

Cancer is a major cause of morbidity and mortality worldwide. It is estimated that in 2020 there were 19.3 million new cancer cases, 10.0 million cancer deaths, and 50.6 million survivors with cancer diagnosed up to 5 years previously [1]. Comparison of cancer incidence between countries and between areas within countries can reveal peaks and troughs indicating varying patterns of risk.
In this study we analysed cancer incidence in countries of Latin America, the Caribbean, and Europe, belonging to the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL) [2]. GRELL countries have historical, cultural, and linguistic ties, but are widely separated geographically and have differing health systems and public health policies, also the risk factors for cancer show a very heterogeneous geographical distribution. For example the fraction (%) of all-cancers among males attributable to excess body mass index went in the GRELL countries from 1.3 (Ecuador) to 4.5 (Argentina), among females from 4.7 (Peru) to 11.6 (Puerto Rico) [3]. The ASRws attributable to all infectious agents, for males, went from 13.3 (Argentina) to 27.6 (Chile), for females from 20.4 (Uruguay) to 41.7 (Peru) [4]. The fraction (%) of melanoma cases among males attributable to ultraviolet (UV) radiation exposure went from 34.4 (Chile) to 94.4 (Switzerland), among females went from 1.20 (Peru) to 89.4 (Switzerland) [5]. Population weighted ambient concentrations (dust and sea-salt free) of fine particulate matter (PM2.5) between 2001 and 2010 went from 4.9 μg/m3 (Tropical Latin America) to some locations in the Po Valley in Italy exceeding the 35 μg/m3 [6]. Globally a positive relationship between overall cancer incidence and the Human Development Index, a composite index of life expectancy, education, and gross national income was observed, the same pattern was found in the GRELL countries. Usually the studies that compare cancer incidence at an international level compute the ASRws at a country level without considering within country variations [7,8,9,10]. Our aim was to assess whether all-cancer incidence varied between these countries, and also between geographic regions within countries, on the hypothesis that the investigation of regions and individual cancer registry areas would reveal information not evident at the country level. Identification of peaks and troughs indicating varying patterns of risk should stimulate etiologic research, provide indications for health resource allocation, and guide interventions to reduce risks [7,8,9,10].

2. Materials and Methods

2.1. Incidence

We downloaded cancer data pertaining to 108 GRELL cancer registries in 15 countries of Latin America, the Caribbean, and Europe. The more updated cancer incidence data, available on the IARC website [11] and published in Volume XI of Cancer Incidence in Five Continents [12], comprised cancer cases diagnosed in 2008–2012, together with person-years of follow-up, for each cancer site, by age at diagnosis (5-year age classes from 0 years), cancer registry, and sex. We computed age-specific incidence rates for every registry, for 5-year age classes (from 0–4 years to 75+ years), as the quotient of the number of cases and the number of person-years in the respective categories of sex and age-class, expressed per 100,000 person-years. We defined person-years as the sum of the population counts in a specific geographical area surveyed by a registry in the years for which registry data were published in Volume XI of Cancer Incidence in Five Continents, categorized by sex and age class. We estimated cancer incidence per 100,000 using the direct method standardized to the World Standard Population (ASRw), computing the weighted average of the age-specific rates using as weights the World Standard Population.
From these data we estimated cancer incidence per 100,000 using the direct method standardized to the World Standard Population (ASRw). This method is the same as that used by IARC [13], except that we merged age classes from 75 years on, because several registries only made data available for the merged ≥75 year age class. We estimated ASRws for all cancers combined, excluding non-melanoma skin cancer (ICD10 codes C00-C97, except C44) for each country, and also—when incidence variation was high as measured by the method of Crocetti et al. [13]—for geographic regions and sub-regions within countries. We computed the ASRw for countries and regions by using the same method.

2.2. Within-Country Incidence Variation

The variation in incidence within a country, or region within a country, was quantified as r/R, defined, after Crocetti et al., [13] as the difference (r) between the highest and lowest incidence rates for cancer registries within a country/region, divided by the incidence rate for the entire country/region × 100 (R). Crocetti et al. considered that an r/R of ≥30 indicated high (within-country) variation and that an r/R of <15% indicated low variation. We adopted the single r/R threshold of 30%.
The flow chart (Figure 1) illustrates how we proceeded.
We first examined incidence variation (r/R) between the cancer registries within a country (Step 1). When the r/R was <30% we used the overall incidence to represent the whole country. If the r/R was high (≥30%), we divided that country into geographic regions. In Step 2 we analysed the variation of incidence, by cancer registry, within each region. If a regional r/R was <30%, we used the regional incidence as representative of the whole region. If a regional r/R was ≥30%, we identified (Step 3) the cancer registry (or registries) responsible for the high r/R. Therefore, we report incidence rates for countries. However, if within-country incidence variation was high we report incidence rates for regions. Furthermore, if within-region variation was high we indicate the cancer registries responsible for the high variation.

3. Results

3.1. Breakdown of Countries into Regions According to r/R

Table 1A,B, for males and females respectively, show incidence (ASRw) for the 15 GRELL countries analysed, in order of decreasing incidence. Table S1 shows the list of the registries and the sizes of the populations under study by registry and by country. Four countries—Belgium, Costa Rica, Puerto Rico and Uruguay sent in data from nationwide cancer registries, so within-country variations could not be assessed, and only incidence by country is reported. Furthermore, for Portugal and Peru, data were only available for the Azores and Lima cancer registries, respectively, so again, within-country incidence variation could not be assessed. Of the remaining nine countries, seven countries for males were divided into regions because of high within-country incidence variation: Ecuador (r/R = 76.49%), Brazil (55.11%), Colombia (39.60%), Italy (35.13%), France (34.68%), Spain (30.30%), and Argentina (30.07%) (Table S2). Switzerland (11.82%) and Chile (6.41%) were not divided into regions for low within-country incidence variations. For females, five of the nine countries were divided into regions because of high within-country incidence variation: Brazil (83.15%), Ecuador (68.35%), France (44.85%), Argentina (32%) and Italy (33.04%).
Spain (24.58%), Colombia (11.93%), Chile (5.81%) and Switzerland (11.82%) were not divided into regions for low within-country incidence variation (Table S3). For males and females, Argentina [1] was divided into north, central and south; Brazil [2] into north-east, central, and south; Ecuador [3] into north-central, central, south, and Pacific; France [4] into Metropolitan and Overseas; and Italy [5] into north-east, north-west, central, south, and islands. For males only, Spain [6] was divided into north and east and south. As a result of these divisions (i.e., application of Step 2, Figure 1), 28 geographic entities in males (Table 2A) and 27 geographic entities in females (Table 2A) were identified, all now with low within-entity incidence variation.
Finally (Step 3, Figure 1) we isolated the cancer registries of Florianopolis (Brazil) for males and females and Cali (Colombia) for males only, resulting in 30 geographic entities in males and 28 in females.

3.2. Country and Regional Incidence Rates

3.2.1. Males

Cancer incidence in males was higher in all European GRELL countries than all Latin American and Caribbean countries. Italy, the European country with lowest male incidence, was 40 ASRw points higher than Uruguay, the Latin-Caribbean country with highest male incidence (Table 1A). Azores (Portugal) had the highest male cancer incidence (381.92). The registry of Florianopolis (Brazil) had the second highest incidence (380.33), while Brazil was in the middle of the country rankings (272.58, Table 1A), and central and north-east Brazil were in the middle of the entity rankings. Incidence for Spain was 339.97 overall (Table 1A), with north and east Spain (Table 2A) at 357.91, and south Spain nearly 50 ASRw points lower at 308.34. As a country, France had the second highest male incidence (369.35). After dividing France into Metropolitan and Overseas areas, incidence in Metropolitan France remained high (372.25) while incidence in Overseas France was over 60 ASRw points lower than Metropolitan France. Belgium (364.28, country only) had a very similar incidence to the registries of France as a whole. Switzerland (338.22, country only) had similar incidence to Italy (331.81) but higher incidence than Brazil (258.28), while Florianopolis (Brazil) and north-west and north-east Italy had considerably higher incidence levels. Italy had the sixth highest incidence (Table 1A), and considerable incidence variation, with north-west and north-east Italy over 50 ASRw points higher than the Islands of Italy. Argentina (215.22) was split into high incidence central Argentina (222.12) and low incidence north Argentina (189.68) and south Argentina (173.24). As a country Colombia was near the bottom of Table 1A (179.15), but the cancer registry of Colombia-Cali had much higher incidence (204.49) than the Rest of Colombia (149.97). Costa Rica (173.90, country only) had a very similar incidence to the registries of Colombia as a whole. Ecuador had a similar pattern: as a country it had the lowest incidence in the GRELL area (135.11), but incidence varied widely: 192.79 for central-north Ecuador, 168.50 for south Ecuador, 125.43 for central Ecuador, and 89.45 for Pacific Ecuador.

3.2.2. Females

As with males, cancer incidence was generally higher for females in European GRELL countries than Latin American/Caribbean countries (Table 1B). However there was an exception: Uruguay had higher incidence than Spain and Azores (Portugal). For Brazil, incidence for females was middle-ranking (199.34) but varied markedly by geographic entity: 338.43 in Florianopolis (highest in GRELL area), 208.57 in north-east Brazil, 194.18 in central Brazil, and 179.99 in south Brazil. Belgium had the highest country incidence (289.21, Table 1B) but Florianopolis was ranked at the top of Table 2B with an incidence nearly 50 ASRw points higher than Belgium. Italy (Table 1B) had the second highest incidence in females (264.22) but again with considerable geographic variation: from 281.59, 268.03 and 267.75, respectively, in north-east, central and north-west Italy, to 240.80 and 237.76 in south Italy and the islands. Female cancer incidence in Metropolitan France (262.20) and Switzerland (261.41) fell within the incidence range of the Italian regions, while Overseas France had low incidence (181.03). Spain, with middle-ranking female cancer incidence, was not split into regions because of limited within-country incidence variation. By contrast, Argentina was characterized by wide within-country incidence variation: 201.16 for the whole country (middle ranking), 207.66 for central Argentina, 174.77 for north Argentina, and 149.16 for south Argentina. Incidence for Costa Rica, Colombia, Ecuador, Peru (Lima only), Puerto Rico and Chile was low (bottom of Table 1B). For Colombia and Chile within-country incidence variation was low. Within Ecuador (152.43) there was marked variation: central Ecuador (144.88) and Pacific Ecuador (102.32) had low incidence; central-north Ecuador had much higher incidence (199.11).

3.2.3. Comparisons

Table 3 shows ratios of highest to lowest ASRws for countries, regions, and cancer registries. For countries the ratios were 2.8 for males and 1.9 for females. For regions the ratios were 4.3 for males and 3.3 for females. For cancer registries the respective ratios were 4.8 and 3.3—closely similar to the regional ratios. The ten cancer registries with the highest all-cancer incidence in males, in order of decreasing incidence were Lille-Métropole (France), Loire-Atlantique (France), Doubs (France), Biella (Italy), Territoire de Belfort (France), Basque Country (Spain), Azores (Portugal), Florianopolis (Brazil), Sondrio (Italy) and Calvados (France). (Supplementary Table S2).
The 10 registries with the highest all-cancer incidence in females, in order of decreasing incidence were Florianopolis (Brazil), Parma (Italy), Romagna (Italy), Modena (Italy), Ferrara (Italy), Lille-Métropole (France), Belgium, Biella (Italy), Mantua (Italy), and Piacenza (Italy) (Supplementary Table S3).

4. Discussion

The aim of this study was to assess, by analysing data from 108 GRELL cancer registries in 15 countries of Latin America, the Caribbean, and Europe, the degree of variation in all-cancer incidence between countries, and also between geographic regions within countries, on the hypothesis that investigation of regions and individual cancer registry areas would reveal information not evident at the country level.
Crocetti et al. [13] found that neither 95% confidence intervals nor standard errors for national (or supra-national) incidence data provided reliable indications of within (or between) country variation in incidence, since both were largely dependent on the number of cases considered. In the present study, therefore, we used the r/R indicator proposed by Crocetti et al. [13] to identify marked within-country incidence variation and separate out the regions and individual cancer registries responsible for that variation.
Among the nine countries whose within-country incidence could be assessed, we found that seven countries for males and five countries for females could be divided into regions because of high within-country incidence variation, resulting in the identification of several high incidence areas (i.e., Florianopolis, Brazil; north and east Spain; north-east Italy) that were invisible when only incidence by country was considered. These findings suggest that our classification method is useful as it implies we succeeded in identifying the main incidence variations by isolating regions and cancer registries whose incidences differed most markedly.
To the best of our knowledge few studies have assessed all-cancer incidence variation between and within countries. Crocetti et al. [13] assessed all cancer incidence variation between and within Nordic countries. The study of Li et al. [14] investigated geographic variations in kidney cancer incidence in European countries, finding marked between and within country variations. The authors concluded that while between-country variations could be influenced by variation in diagnostic and clinical practice, but within-country variations were most likely due to yet-to-be-pinpointed environmental factors that require further investigation. Some studies tried to assess the site-specific cancer burden and their associated risk factors [15,16] using available country-level data for the population exposure to risk factors. The same data on risk factor distribution at a within country level were not currently easily available which limits the possibility to interpret some of the differences we observed without performing high-definition studies. However, some hypothesis could be suggested by looking at specific areas, for example, the differences in ASRw between north-east and north-west regions of Italy with respect to those of the south and the islands could be hypothesized to be linked to differences in diet, more Mediterranean in the south and the islands with respect to that of north-east and north-west [17] and to be linked to a different exposure of the populations to PM2.5 [6].
The most noteworthy finding of the present study is that the area covered by the Florianopolis (Brazil) cancer registry had particularly high all-cancer incidence, both in males and females: incidence was much higher than in other Brazilian regions, and up with the highest in Europe. Florianopolis is a costal and island city in the state of Santa Catarina in the south of Brazil. It has little heavy industry, and its economy is based mainly on information technology, tourism and services [18]. It is a wealthy area and it is possible that its residents may have more sedentary lifestyles, and consume more unhealthy foods, tobacco and alcohol, than populations of less wealthy parts of Brazil. However the exceptionally high rate suggests the possibility of a local environmental cause. Similar factors may account for the very high all-cancer incidence among males in the Azores, a group of volcanic islands in the middle of the Atlantic.
We also found high incidence for males in the cancer registry of Cali (204.49) compared to the rest of Colombia (149.97), however it is possible that Cali, the most ancient cancer registry in Latin America, suffered from less incompleteness of cancer registration than other cancer registries of the rest of Colombia [19,20,21].
Central-north Ecuador (192.79) also had high incidence compared with other regions of Ecuador (89.45–168.50). The north-central part of Ecuador corresponds in fact to the cancer registry that covers the city of Quito, the capital of Ecuador, and it is possible that many patients who do not normally reside in the city go there for treatment and this produces an over-registration with the corresponding artificial increase in incidence. These hotspots were not evident from nationally aggregated data and suggest the need for specific investigations that may reveal modifiable risk factors in these increased-risk populations.
We found that the ratio of the highest to lowest incidence in the GRELL regions we identified was 4.3 for males and 3.3 for females. These high ratios suggest that a large proportion of cases from high incidence areas are preventable. It has been estimated that between a third and a half of all cancers are preventable because they are due to modifiable risk factors (diet, lifestyle, environmental and occupational exposure to carcinogens and infectious agents), while non-modifiable factors, such as genetics, may only account for 4–5% of cases [16,22,23,24,25].
Social inequalities are among the factors likely to contribute to the within-country variations in cancer incidence we found. These inequalities, rooted in differences in income, education and opportunity, and also racial and sex discrimination, impact the most disadvantaged individuals, communities, and countries and strongly correlate with variations in cancer incidence, survival, and mortality between and within countries [25,26]. Social inequalities are also linked to different exposures to environmental carcinogens resulting in what has been termed environmental injustice [27,28,29,30,31,32]. Analyses that assess within-country variations in cancer incidence may, therefore, be a starting point for revealing such injustice.
A possible limitation of this study is that the cancer registries analysed may differ in completeness and data quality [19], however the data we used had been accepted by the IARC for CI5 after numerous data quality checks had been performed [33].
This main limitations of the present study arise from that fact that for several GRELL countries, incidence is available only in nationally aggregated form, rendering the identification of hotspots impossible. It is also impossible to identify hotspots in countries represented by cancer registries that cover just a small fraction of the area and population of those countries: The most conspicuous example in this study is Portugal which is represented solely by the small offshore registry of Azores. Old data suggest that incidence rates on mainland Portugal are much lower than those in the Azores [34]. We also emphasize that many of the countries investigated do not have nation-wide cancer registration so the within-country variations in cancer incidence we have documented are likely to be underestimates.

5. Conclusions

To conclude, this study has identified within-country regions whose all cancer incidence rates are three to four-fold higher than those in other regions in the GRELL area. It is likely that such differences (particularly in Italy, Spain, Colombia and Ecuador) are beyond differences in registration completeness and reflect differences in levels of industrialisation and economic development, which in turn increase occupational and environmental exposure to carcinogens and adversely affect lifestyle factors that increase cancer risk. For other high incidence areas such as Florianopolis and Azores, other explanations are possible and deserve further investigation. Our findings suggest that national cancer incidence statistics should also be published by region or individual cancer registry and not agglomerated at the country level. We think that studies investigating incidence for specific cancer sites have to be encouraged in the GRELL area.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ijerph18179262/s1, Table S1: Average annual person years by registry, Table S2: Overall, highest and lowest incidence (ASRw) in males, with r/R, for each geographic entity, Table S3: Overall, highest and lowest incidence (ASRw) in females with r/R, for each geographic entity.

Author Contributions

Conceptualization, P.C. and G.T.; Methodology, P.C. and G.T.; Validation, P.C., J.G., J.-L.B., E.C., G.T., G.G., M.B., A.S. and GRELL Geographic Analysis Working Group; Investigation, P.C., M.B. and A.S.; Data collection, GRELL Geographic Analysis Working Group; Writing—Original Draft Preparation, P.C.; Writing—Review and Editing, P.C., J.G., J.-L.B., E.C., G.T., G.G., M.B., A.S. and GRELL Geographic Analysis Working Group; Supervision, P.C.; Project Administration, P.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

In this study we used only aggregated data available on web-sites accessible to the public.

Acknowledgments

The authors thank Don Ward for help with the English and for critically reading the manuscript. GRELL Geographic Analysis Working Group: Hospital de Urgência de Sergipe Gov. João Alves Filho, Aracaju, Brazil (Carlos A. Lima), Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil, (Hianga Fayssa Siqueira), Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil. (Marcela Sampaio Lima), Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Sergipe, Brazil, (Erika Costa Brito), Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia (Claudia Janeth Uribe), Institute of Cancer SOLCA-Cuenca, Ecuador (Fray Cleiton Martinez Reyes), Belgian Cancer Registry, Brussels, Belgium, (Julie Francart), Luxembourg CR (Sophie Couffignal), Claudius Regaud Institute, IUCT-O, Tarn Cancer Registry, Toulouse, France (Pascale Grosclaude), Grenoble University Hospital, France (Marc Colonna), University Hospital of Guadeloupe, Pointe-à-Pitre, Guadeloupe, France (Jacqueline Deloumeaux), Portuguese Oncology Institute of Porto, Portugal (Clara Castro), Registo Oncológico do Sul (Ana Miranda), Tarragona CR, Spain (Jaume Galceran), CIBER de Epidemiología y Salud Pública, CIBERESP FEDER-ERDF Instituto de Salud Carlos III, Madrid, Spain; Grupo de Investigación Riesgo Vascular en Navarra (RIVANA), Departamento de Salud, Gobierno de Navarra, Pamplona, Spain; Instituto de Salud Pública de Navarra, Departamento de Salud, Gobierno de Navarra, Pamplona, Spain (Eva Ardanaz Aicua), Hospitales Universitarios de Granada, Spain (Maria-Jose Sanchez-Perez), Epidemiology Unit and Girona Cancer Registry (UERCG), Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), University of Girona, Girona, Spain (Rafael Marcos-Gragera), Vaud Tumour Registry, Centre for Primary Care and Public Health (Jean-Luc Bulliard), Geneva Cancer Registry, Global Health Institute, University of Geneva, Geneva, Switzerland (Robin Schaffar), Cancer Registry St. Gallen and Appenzell, St. Gallen, Switzerland (Christian Herrmann), Cancer Registry St. Gallen and Appenzell, St. Gallen, Switzerland (Mohsen Mousavi), Valais Cancer Registry, Valais, Switzerland (Isabelle Konzelmann),Epidemiologic Observatory, Cancer Registry, ATS di Pavia, Pavia, Italy (Lorenza Boschetti), Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7) Ragusa, Italy (Rosario Tumino), Sondrio Cancer Registry, Sondrio, Italy (Anna Clara Fanetti), Institute for cancer research, prevention and clinical network (ISPRO), Florence, Italy (Adele Caldarella), Institute for cancer research, prevention and clinical network (ISPRO), Florence, Italy (Teresa Intrieri), Romagna Cancer Registry, Romagna Cancer Institute (IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) “Dino Amadori”), Meldola, Forlì, Italy (Emanuele Crocetti), Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy (Andrea Tittarelli), Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy (Sabrina Fabiano), Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy (Viviana Perotti), Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy (Giovanna Tagliabue), Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale (Alessandro Borgini), Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale (Martina Bertoldi), Environmental Epidemiology Unit, Fondazione IRCCS Istituto Nazionale (Paolo Contiero), Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy (Gemma Gatta), Aosta Valley CR, Aosta, Italy (Maurizio Castelli), Aosta Valley CR, Aosta, Italy (Salvatore Bongiorno).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Global Cancer Observatory (IARC): Global Cancer Burden in 2020. Available online: https://infogram.com/globocan-2020-1h9j6qg7xdp8v4g?live (accessed on 26 August 2021).
  2. Group for Cancer Epidemiology and Registration in Latin Language Countries. Available online: https://www.grell-network.org (accessed on 26 August 2021).
  3. International Agency for the Research on Cancer, Global Cancer Observatory. Available online: https://gco.iarc.fr/causes/obesity (accessed on 26 August 2021).
  4. International Agency for the Research on Cancer, Global Cancer Observatory. Available online: https://gco.iarc.fr/causes/infections (accessed on 26 August 2021).
  5. International Agency for the Research on Cancer, Global Cancer Observatory. Available online: https://gco.iarc.fr/causes/uv (accessed on 26 August 2021).
  6. Van Donkelaar, A.; Martin, R.V.; Brauer, M.; Boys, B.L. Use of satellite observations for long-term exposure assessment of global concentrations of fine particulate matter. Environ. Health Perspect. 2015, 123, 135–143. [Google Scholar] [CrossRef] [Green Version]
  7. Miranda-Filho, A.; Piñeros, M.; Ferlay, J.; Soerjomataram, I.; Monnereau, A.; Bray, F. Global patterns and trends in the incidence of non- Hodgkin lymphoma. Cancer Causes Control 2019, 30, 489–499. [Google Scholar] [CrossRef]
  8. Miranda-Filho, A.; Piñeros, M.; Ferlay, J.; Soerjomataram, I.; Monnereau, A.; Bray, F. Epidemiological patterns of leukaemia in 184 countries: A population-based study. Lancet Haematol. 2018, 5, e14–e24. [Google Scholar] [CrossRef]
  9. Steliarova-Foucher, E.; Fidler, M.M.; Colombet, M.; Lacour, B.; Kaatsch, P.; Piñeros, M.; Soerjomataram, I.; Bray, F.; Coebergh, J.W.; Peris-Bonet, R.; et al. ACCIS contributors. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): A population-based study. Lancet Oncol. 2018, 19, 1159–1169. [Google Scholar] [CrossRef] [Green Version]
  10. Bell, J.S.; Koffie, R.M.; Rattani, A.; Dewan, M.C.; Baticulon, R.E.; Qureshi, M.M.; Wahjoepramono, E.J.; Rosseau, G.; Park, K.; Nahed, B.V. Global incidence of brain and spinal tumors by geographic region and income level based on cancer registry data. J. Clin. Neurosci. 2019, 66, 121–127. [Google Scholar] [CrossRef]
  11. Cancer Incidence in Five Continents. Vol XI. Available online: http://ci5.iarc.fr/CI5-XI/Default.aspx (accessed on 26 August 2021).
  12. Bray, F.; Colombet, M.; Mery, L.; Piñeros, M.; Znaor, A.; Zanetti, R.; Ferlay, J. (Eds.) Cancer Incidence in Five Continents, Volume XI (Electronic Version); International Agency for Research on Cancer: Lyon, France, 2017; Available online: http://ci5.iarc.fr (accessed on 26 August 2021).
  13. Crocetti, E.; Giusti, F.; Martos, C.; Randi, G.; Dyba, T.; Bettio, M. Variability of cancer risk within an area: Time to complement the incidence rate. Eur. J. Cancer Prev. 2017, 26, 442–444. [Google Scholar] [CrossRef] [Green Version]
  14. Li, P.; Znaor, A.; Holcatova, I.; Fabianova, E.; Mates, D.; Wozniak, M.B.; Ferlay, J.; Scelo, G. Regional geographic variations in kidney cancer incidence rates in European countries. Eur. Urol. 2015, 67, 1134–1141. [Google Scholar] [CrossRef] [PubMed]
  15. GBD 2019 Respiratory Tract Cancers Collaborators. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir. Med. 2021, 16, S2213–S2600. [Google Scholar]
  16. Arnold, M.; Pandeya, N.; Byrnes, G.; Renehan, P.A.G.; Stevens, G.A.; Ezzati, P.M.; Ferlay, J.; Miranda, J.J.; Romieu, I.; Dikshit, R.; et al. Global burden of cancer attributable to high body-mass index in 2012: A population-based study. Lancet Oncol. 2015, 16, 36–46. [Google Scholar] [CrossRef]
  17. Giampaoli, S.; Krogh, V.; Grioni, S.; Palmieri, L.; Gulizia, M.M.; Stamler, J.; Vanuzzo, D. Gruppo di ricerca dell′Osservatorio epidemiologico cardiovascolare/Health Examination Survey. Comportamenti alimentari degli italiani: Risultati dell′Osservatorio epidemiologico cardiovascolare/Health Examination Survey [Eating behaviours of italian adults: Results of the Osservatorio epidemiologico cardiovascolare/Health Examination Survey]. Epidemiol. Prev. 2015, 39, 373–379. [Google Scholar] [PubMed]
  18. Available online: https://en.wikipedia.org/wiki/Florianópolis (accessed on 26 August 2021).
  19. Sierra, M.S.; Soerjomataram, I.; Antoni, S.; Laversanne, M.; Piñeros, M.; de Vries, E.; Forman, D. Cancer patterns and trends in Central and South America. Cancer Epidemiol. 2016, 44 (Suppl. 1), S23–S42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Pardo, C.; Bravo, L.E.; Uribe, C.; Lopez, G.; Yepez, M.C.; Navarro, E.; de Vries, E.; Pineros, M. Comprehensive assessment of population-based cancer registries: An experience in Colombia. J. Regist. Manag. 2014, 41, 128–134. [Google Scholar]
  21. Cendales, R.; Pardo, C.; Uribe, C.; López, G.; Yepez, M.C.; Bravo, L.E. Data quality at population-based cancer registries in Colombia. Biomedica 2012, 32, 536–544. [Google Scholar] [CrossRef]
  22. Vineis, P.; Wild, C.P. Global cancer patterns: Causes and prevention. Lancet 2014, 383, 549–555. [Google Scholar] [CrossRef]
  23. Plummer, M.; de Martel, C.; Vignat, J.; Ferlay, J.; Bray, F.; Franceschi, S. Global burden of cancers attributable to infections in 2012: A synthetic analysis. Lancet Glob. Health 2016, 4, e609–e616. [Google Scholar] [CrossRef] [Green Version]
  24. Prüss-Ustün, A.; Wolf, J.; Corvalán, C.; Neville, T.; Bos, R.; Neira, M. Diseases due to unhealthy environments: An updated estimate of the global burden of disease attributable to environmental determinants of health. J. Public Health 2017, 39, 464–475. [Google Scholar] [CrossRef] [PubMed]
  25. Raaschou-Nielsen, O.; Andersen, Z.J.; Beelen, R.; Samoli, E.; Stafoggia, M.; Weinmayr, G.; Hoffmann, B.; Fischer, P.; Nieuwenhuijsen, M.J.; Brunekreef, B.; et al. Air pollution and lung cancer incidence in 17 European cohorts: Prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol. 2013, 14, 813–822. [Google Scholar] [CrossRef]
  26. De Souza, J.A.; Hunt, B.; Asirwa, F.C.; Adebamowo, C.; Lopes, G. Global health equity: Cancer care outcome disparities in high-, middle-, and low-income countries. J. Clin. Oncol. 2016, 34, 6–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Vaccarella, S.; Lortet-Tieulent, J.; Saracci, R.; Fidler, M.M.; Conway, D.I.; Vilahur, N.; Sarfati, D.; Jemal, A.; Mackenbach, J.P.; Marmot, M.G.; et al. Reducing Social Inequalities in Cancer: Setting Priorities for Research. CA Cancer J. Clin. 2018, 68, 324–326. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Vaccarella, S.; De Vries, E.; Sierra, M.S.; Conway, D.I.; Mackenbach, J.P. Chapter 6: Social inequalities in cancer within countries. In Reducing Social Inequalities in Cancer: Evidence and Priorities for Research; Vaccarella, S., Lortet-Tieulent, J., Saracci, R., Conway, D.I., Straif, K., Wild, C.P., Eds.; IARC Scientific Publications: Lyon, France, 2019. [Google Scholar]
  29. Fidler, M.M.; Vaccarella, S.; Bray, F. Social inequalities in cancer between countries. In Reducing Social Inequalities in Cancer: Evidence and Priorities for Research; Vaccarella, S., Lortet-Tieulent, J., Saracci, R., Conway, D.I., Straif, K., Wild, C.P., Eds.; IARC Scientific Publications: Lyon, France, 2019. [Google Scholar]
  30. Goss, P.E.; Lee, B.L.; Badovinac-Crnjevic, T.; Strasser-Weippl, K.; Chavarri-Guerra, Y.; St Louis, J.; Villarreal-Garza, C.; Unger-Saldaña, K.; Ferreyra, M.; Debiasi, M.; et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013, 14, 391–436. [Google Scholar] [CrossRef] [PubMed]
  31. EPA (United States Environmental Protection Agency): Environmental Justice. Available online: https://www.epa.gov/environmentaljustice/learn-about-environmental-justice (accessed on 26 August 2021).
  32. Fairburn, J.; Schüle, S.A.; Dreger, S.; Karla Hilz, L.; Bolte, G. Social Inequalities in Exposure to Ambient Air Pollution: A Systematic Review in the WHO European Region. Int. J. Environ. Res. Public Health 2019, 16, 3127. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Cancer Incidence in Five Continents. Chapter 5: Data Comparability and Quality. Available online: https://ci5.iarc.fr/CI5-XI/PDF/Chapter%205.pdf (accessed on 26 August 2021).
  34. ECIS—European Cancer Information System. Available online: https://ecis.jrc.ec.europa.eu/explorer.php (accessed on 26 August 2021).
Ijerph 18 09262 g001 550
Figure 1. Flow-chart illustrating how geographic entities were defined according to variation in age-standardized incidence rates (ASRw).
Figure 1. Flow-chart illustrating how geographic entities were defined according to variation in age-standardized incidence rates (ASRw).
Ijerph 18 09262 g001
Table
Table 1. Age-standardized incidence rates in males (A) and females (B) for all cancers combined (except non-melanoma skin cancer) in Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL) countries for the years 2008–2012. Rates are per 100,000 person-years and age-standardized to the world population (ASRw). Countries are listed in descending order of incidence.
Table 1. Age-standardized incidence rates in males (A) and females (B) for all cancers combined (except non-melanoma skin cancer) in Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL) countries for the years 2008–2012. Rates are per 100,000 person-years and age-standardized to the world population (ASRw). Countries are listed in descending order of incidence.
1A1B
CountryIncidence MalesCountryIncidence Females
Portugal (Azores)381.92Belgium *289.21
France369.35Italy264.22
Belgium *364.28Switzerland261.41
Spain339.97France258.36
Switzerland338.22Uruguay *216.77
Italy331.81Spain210.56
Uruguay *289.56Portugal (Azores)209.67
Brazil272.58Argentina201.16
Puerto Rico *258.28Brazil199.34
Argentina215.22Puerto Rico *197.95
Chile209.75Peru (Lima)187.51
Peru (Lima)187.04Chile174.99
Colombia179.15Colombia171.71
Costa Rica *173.90Costa Rica *167.25
Ecuador135.11Ecuador152.43
* Countries that sent in data from nationwide cancer registries, so within-country variations could not be assessed.
Table
Table 2. Age-standardized incidence rates in males (A) and females (B) for all cancers combined (except non-melanoma skin cancer) for geographic entities (countries, regions and cancer registries) characterized by low within-entity incidence variation (identified in Step 3, Figure 1). Incidence years are 2008–2012; rates are per 100,000 person-years, age-standardized to the world population (ASRw) and listed in descending order of incidence.
Table 2. Age-standardized incidence rates in males (A) and females (B) for all cancers combined (except non-melanoma skin cancer) for geographic entities (countries, regions and cancer registries) characterized by low within-entity incidence variation (identified in Step 3, Figure 1). Incidence years are 2008–2012; rates are per 100,000 person-years, age-standardized to the world population (ASRw) and listed in descending order of incidence.
RegionIncidence MalesRegionIncidence Females
Azores, Portugal381.92Florianopolis, Brazil *338.43
Florianopolis, Brazil *380.33Belgium **289.21
Metropolitan France372.25North-east Italy281.59
Belgium **364.28Central Italy268.03
North-east Spain357.91North-west Italy267.75
North-east Italy346.53Metropolitan France262.20
North-west Italy343.67Switzerland261.41
Switzerland338.22South Italy240.80
Central Italy324.55Islands of Italy237.76
South Italy317.03Uruguay **216.77
South Spain308.34Spain210.56
Overseas France304.79Azores, Portugal209.67
Central Brazil301.67North-east Brazil208.57
Islands of Italy292.27Central Argentina207.66
Uruguay **289.56South Ecuador206.51
North-east Brazil281.88Central-north Ecuador199.11
Puerto Rico **258.28Puerto Rico **197.95
South Brazil235.58Central Brazil194.18
Central Argentina222.12Lima (Peru)187.51
Chile209.75Overseas France181.03
Cali,* Colombia204.49South Brazil179.99
Central-north Ecuador192.79Chile174.99
North Argentina189.68North Argentina174.77
Lima (Peru)187.04Costa Rica **167.25
Costa Rica **173.90Colombia171.71
South Argentina173.24South Argentina149.16
South Ecuador168.50Central Ecuador144.88
Rest of Colombia149.97Pacific Ecuador102.32
Central Ecuador125.43
Pacific Ecuador89.45
* Cancer registries responsible for high within-region incidence variation; ** Countries that sent in data from nationwide cancer registries, so within-country variations could not be assessed.
Table
Table 3. Ratios of highest-to-lowest incidence rate in GRELL countries, regions and cancer registries, by sex.
Table 3. Ratios of highest-to-lowest incidence rate in GRELL countries, regions and cancer registries, by sex.
CountriesRegionsCancer Registries
Males2.84.34.8
Females1.93.33.3
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Contiero, P.; Tagliabue, G.; Gatta, G.; Galceran, J.; Bulliard, J.-L.; Bertoldi, M.; Scaburri, A.; Crocetti, E.; on behalf of the GRELL Geographic Analysis Working Group. Variation of Cancer Incidence between and within GRELL Countries. Int. J. Environ. Res. Public Health 2021, 18, 9262. https://doi.org/10.3390/ijerph18179262

AMA Style

Contiero P, Tagliabue G, Gatta G, Galceran J, Bulliard J-L, Bertoldi M, Scaburri A, Crocetti E, on behalf of the GRELL Geographic Analysis Working Group. Variation of Cancer Incidence between and within GRELL Countries. International Journal of Environmental Research and Public Health. 2021; 18(17):9262. https://doi.org/10.3390/ijerph18179262

Chicago/Turabian Style

Contiero, Paolo, Giovanna Tagliabue, Gemma Gatta, Jaume Galceran, Jean-Luc Bulliard, Martina Bertoldi, Alessandra Scaburri, Emanuele Crocetti, and on behalf of the GRELL Geographic Analysis Working Group. 2021. "Variation of Cancer Incidence between and within GRELL Countries" International Journal of Environmental Research and Public Health 18, no. 17: 9262. https://doi.org/10.3390/ijerph18179262

APA Style

Contiero, P., Tagliabue, G., Gatta, G., Galceran, J., Bulliard, J. -L., Bertoldi, M., Scaburri, A., Crocetti, E., & on behalf of the GRELL Geographic Analysis Working Group. (2021). Variation of Cancer Incidence between and within GRELL Countries. International Journal of Environmental Research and Public Health, 18(17), 9262. https://doi.org/10.3390/ijerph18179262

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop